Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-04

Clinical Trial Update: Silkworm Pupa Powder Improves Dementia. [NA]

View source ↗

Summary

The clinical trial update shows recruitment for evaluating silkworm pupa powder as a potential treatment for Alzheimer's disease, sarcopenia, and asthenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Silkworm Pupa Powder

Snippet

Sponsor: Zhejiang Provincial Tongde Hospital | Conditions: Alzheimer Disease(AD), Sarcopenia | NA | Status: RECRUITING